← All organizations

Barrier Therapeutics

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

First marketed drug

First NDA

Last known activity

Feb 16, 2006

Acquired by Stiefel Laboratories → GlaxoSmithKline on Jan 1, 2008

Timeline

2000s

Jan 1, 2001
Barrier Therapeutics— Founded
Feb 16, 2006
zinc oxide— NDA Organization
Jan 1, 2008
Stiefel Laboratories— Acquired By
Jan 1, 2009
GlaxoSmithKline— Now

Indications

Approved for

Marketed drugs (1)

zinc oxide

Details

Founded: Princeton, NJ, US Jan 1, 2001
First NDA: Feb 16, 2006
Last known activity: Feb 16, 2006